This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Medico Consl Co., Ltd.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Toru Kono: Innovator in Non-Alcoholic Steatohepatitis Treatment
Introduction
Toru Kono is a notable inventor based in Hokkaido, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of non-alcoholic steatohepatitis (NASH). His innovative approach combines polaprezinc and sodium selenite to provide a therapeutic solution for this condition.
Latest Patents
Toru Kono holds a patent for a method of treating non-alcoholic steatohepatitis (NASH). The patent describes a method that includes administering a therapeutically effective amount of a pharmaceutical composition containing polaprezinc as a zinc preparation and sodium selenite as a selenium preparation. This innovative treatment offers hope for individuals suffering from NASH.
Career Highlights
Throughout his career, Kono has worked with various companies, including Medico Consl Co., Ltd. and Yamaguchi, Kikuji. His experience in these organizations has contributed to his expertise in developing effective treatments for medical conditions.
Collaborations
Toru Kono has collaborated with notable individuals in his field, including Satoru Kubota and Kikuji Yamaguchi. These partnerships have enhanced his research and development efforts, leading to advancements in medical treatments.
Conclusion
Toru Kono's work in the treatment of non-alcoholic steatohepatitis showcases his dedication to medical innovation. His patent and collaborations reflect his commitment to improving health outcomes for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile